Related Experiment Video
Updated: Jul 11, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Interleukin-6 and the determinants of severe COVID-19: A retrospective cohort study
Wael Hafez1,2, Prashant Nasa3, Ahmed Khairy1
1Internal Medicine, NMC Royal Hospital, Khalifa City, Abu Dhabi, United Arab Emirates.
Insights
Elevated interleukin-6 (IL-6) levels correlate with severe COVID-19 and increased mortality risk. Understanding IL-6 and patient characteristics aids in predicting severe disease and guiding early treatment strategies for coronavirus disease 2019.
Area of Science:
- Immunology
- Infectious Diseases
- Clinical Medicine
Background:
- Severe COVID-19 is linked to elevated cytokine levels, particularly interleukin-6 (IL-6).
- High IL-6 levels may indicate a heightened immune response, potentially leading to organ failure or death.
- Predicting COVID-19 severity and patient outcomes is crucial for timely therapeutic interventions.
Purpose of the Study:
- To investigate the association between serum IL-6 levels and COVID-19 severity.
- To examine demographic, clinical, and biochemical factors related to IL-6 levels and disease severity.
- To identify predictors of severe COVID-19 for early intervention strategies.
Main Methods:
- A cohort study of 374 COVID-19 inpatients was conducted between November 2020 and November 2021.
- Serum IL-6 levels, demographic data, clinical characteristics, and biochemical markers were analyzed.
- Statistical analyses, including univariate and multivariate analyses, were performed to assess associations.
Main Results:
- The elderly population showed a higher risk for severe COVID-19.
- Higher levels of white blood cells, D-dimer, lactate dehydrogenase, creatinine, ferritin, prothrombin time, procalcitonin, and fibrinogen were observed in severe cases.
- While univariate analysis showed associations between higher IL-6 and C-reactive protein, troponin, ICU admission, severity score, and mortality, these did not persist in multivariate analysis.
Conclusions:
- Serum IL-6 levels, alongside demographic and clinical variables, influence COVID-19 severity.
- Identifying patients at risk for severe disease is possible through analysis of these characteristics.
- Further large-scale research is warranted to elucidate the role of IL-6 in COVID-19 outcomes.
Abstract:
Cytokines, notably interleukin-6 (IL-6), increase considerably in patients with severe corona virus disease 2019 (COVID-19). This vigorous immune response may cause end-organ failure or death; hence, measuring IL-6 in the context of patient characteristics may help predict outcomes and encourage early comprehensive therapy. This study investigated the association between serum IL-6 levels, COVID-19 severity, and demographic, clinical, and biochemical characteristics. COVID-19 inpatients in NMC hospitals were investigated between November 2020 and November 2021. Several patient variables related to serum IL-6 and COVID-19 severity have been examined. The study included 374 COVID-19 inpatients, 235 of whom had severe disease with a median age of 51. The elderly had an increased risk of severe COVID-19 (73.8%) compared with young adults (71%), with higher white blood cells, D-dimer, Lactate dehydrogenase, creatinine, ferritin, prothrombin time, Procalcitonin, and fibrinogen levels (P < .001). C-reactive protein, troponin, intensive care unit admission, disease severity score, and mortality were significantly associated with higher serum IL-6 levels (P = .05) in the univariate analysis, but this significance disappeared in the multivariate analysis. IL-6, along with other demographic and clinical variables affected COVID-19 severity. These characteristics may predict patients at risk of severe disease and assist in establishing early comprehensive disease outcome strategies. Large-scale clinical research is needed to emphasize IL-6 and COVID-19.
More Related Videos
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway